Experimental Hematology
Volume 34, Issue 11 , Pages 1490-1495 , November 2006

Platelet FcγRIIA binds and internalizes IgG-containing complexes

  • Randall G. Worth

      Affiliations

    • University of Pennsylvania School of Medicine, Philadelphia, Pa., USA
    • Current address: Medical Microbiology & Immunology, University of Toledo College of Medice, 3055 Arlington Ave., Toledo, OH 43614.
  • ,
  • Christopher D. Chien

      Affiliations

    • Cardeza Foundation for Hematologic Research, Thomas Jefferson University, Philadelphia, Pa., USA
  • ,
  • Paul Chien

      Affiliations

    • University of Pennsylvania School of Medicine, Philadelphia, Pa., USA
  • ,
  • Michael P. Reilly

      Affiliations

    • Cardeza Foundation for Hematologic Research, Thomas Jefferson University, Philadelphia, Pa., USA
  • ,
  • Steven E. McKenzie

      Affiliations

    • Cardeza Foundation for Hematologic Research, Thomas Jefferson University, Philadelphia, Pa., USA
  • ,
  • Alan D. Schreiber

      Affiliations

    • University of Pennsylvania School of Medicine, Philadelphia, Pa., USA
    • Corresponding Author InformationOffprint requests to: Alan D. Schreiber, M.D., Division of Hematology & Oncology, 736 BRB II/III, 421 Curie Blvd., Philadelphia, PA 19104

Received 7 March 2006 ,Revised 14 June 2006 ,Accepted 22 June 2006.

References 

  1. Capel PJ, van de Winkel JG, van den Herik-Oudijk IE, Verbeek JS. Heterogeneity of human IgG Fc receptors. Immunomethods. 1994;4:25–34
  2. Daeron M. Fc receptor biology. Annu Rev Immunol. 1997;15:203–234
  3. Zhou MJ, Lublin DM, Link DC, Brown EJ. Distinct tyrosine kinase activation and Triton X-100 insolubility upon Fc γ RII or Fc γ RIIIB ligation in human polymorphonuclear leukocytes. Implications for immune complex activation of the respiratory burst. J Biol Chem. 1995;270:13553–13560
  4. McKenzie SE, Schreiber AD. Biological advances and clinical applications of Fc receptors for IgG. Curr Opin Hematol. 1994;1:45–52
  5. Reilly MP, Taylor SM, Hartman NK, et al. Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcγRIIA. Blood. 2001;98:2442–2447
  6. Cines DB, Kaywin P, Bina M, Tomaski A, Schreiber AD. (1980) Heparin-associated thrombocytopenia. N Engl J Med. 1980;(303):788–795
  7. Kappers-Klunne MC, Boon DM, Hop WC, et al. Heparin-induced thrombocytopenia and thrombosis: a prospective analysis of the incidence in patients with heart and cerebrovascular diseases. Br J Haematol. 1997;96:442–446
  8. Warkentin TE, Hayward CP, Boshkov LK, et al. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood. 1994;84:3691–3699
  9. Chong BH, Pilgrim RL, Cooley MA, Chesterman CN. Increased expression of platelet IgG Fc receptors in immune heparin-induced thrombocytopenia. Blood. 1993;81:988–993
  10. Suh JS, Malik MI, Aster RH, Visentin GP. Characterization of the humoral immune response in heparin-induced thrombocytopenia. Am J Hematol. 1997;54:196–201
  11. Arepally G, McKenzie SE, Jiang XM, Poncz M, Cines DB. Fc γ RIIA H/R 131 polymorphism, subclass-specific IgG anti-heparin/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis. Blood. 1997;89:370–375
  12. Taylor SM, Reilly MP, Schreiber AD, Chien P, Tuckosh JR, McKenzie SE. Thrombosis and shock induced by activating antiplatelet antibodies in human Fc γ RIIA transgenic mice: the interplay among antibody, spleen, and Fc receptor. Blood. 2000;96:4254–4260
  13. Arnout J, Vermylen J. Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease. J Thromb Haemost. 2003;1:931–942
  14. Canobbio I, Bertoni A, Lova P, et al. Platelet activation by von Willebrand factor requires coordinated signaling through thromboxane A2 and Fc γ IIA receptor. J Biol Chem. 2001;2001(276):26022–26029
  15. King M, McDermott P, Schreiber AD. Characterization of the Fc γ receptor on human platelets. Cell Immunol. 1990;128:462–479
  16. McKenzie SE, Taylor SM, Malladi P, et al. The role of the human Fc receptor Fc γ RIIA in the immune clearance of platelets: a transgenic mouse model. J Immunol. 1999;162:4311–4318
  17. Daukas G, Zigmond SH. Inhibition of receptor-mediated but not fluid-phase endocytosis in polymorphonuclear leukocytes. J Cell Biol. 1985;101:1673–1679
  18. Heuser JE, Anderson RG. Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. J Cell Biol. 1989;108:389–400
  19. Hansen SH, Sandvig K, van Deurs B. Clathrin and HA2 adaptors: effects of potassium depletion, hypertonic medium, and cytosol acidification. J Cell Biol. 1993;121:61–72
  20. Petty HR, McConnell HM. Cytochemical study of liposome and lipid vesicle phagocytosis. Biochim Biophys Acta. 1983;735:77–85
  21. Worth RG, Mayo-Bond L, van de Winkel JG, Todd RF, Petty HR. CR3 (αM β2; CD11b/CD18) restores IgG-dependent phagocytosis in transfectants expressing a phagocytosis-defective Fc γRIIA (CD32) tail-minus mutant. J Immunol. 1996;157:5660–5665
  22. Spurr AR. A low-viscosity epoxy resin embedding medium for electron microscopy. J Ultrastruct Res. 1969;26:31–43
  23. Unkeless JC. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med. 1979;150:580–596
  24. Youssefian T, Drouin A, Masse JM, Guichard J, Cramer EM. Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation. Blood. 2002;99:4021–4029
  25. Lee JC, Tripathy K. Neutrophilic thrombophagocytosis. Arch Pathol Lab Med. 2000;124:1545–1546
  26. Peters MJ, Dixon G, Kotowicz KT, Hatch DJ, Heyderman RS, Klein NJ. Circulating platelet-neutrophil complexes represent a subpopulation of activated neutrophils primed for adhesion, phagocytosis and intracellular killing. Br J Haematol. 1999;106:391–399

PII: S0301-472X(06)00410-3

doi: 10.1016/j.exphem.2006.06.015

Experimental Hematology
Volume 34, Issue 11 , Pages 1490-1495 , November 2006